NEW YORK and LONDON, April 3, 2017 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that Dr. …

[Read more...] about Akari Therapeutics to Present at the Jefferies Complement Symposium

NEW YORK and LONDON, March 30th, 2017 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today that …

[Read more...] about Akari Therapeutics Announces FDA Fast Track Designation For Coversin

NEW YORK and LONDON, March 17th, 2017 -- Presentation to Include New Coversin Phase II Data in PNH and Latest Data on Pipeline – Akari Therapeutics …

[Read more...] about Akari Therapeutics Announces R&D Day on April 24, 2017